搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 天
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...
1 天
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
Future Market Insights
15 小时
Canine Atopic Dermatitis Treatment Market Value set to Reach USD 1,620.50 Million by 2034 ...
The canine atopic dermatitis treatment market is set to experience notable growth, with an expected increase from USD ...
Everyday Health
3 天
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval
Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...
GlobalData on MSN
2 天
Aclaris doses first subject in Phase IIa atopic dermatitis treatment trial
Aclaris Therapeutics has dosed the first subject in the Phase IIa clinical trial of ATI-2138 to treat moderate to severe ...
Healthcare Asia on MSN
20 小时
Atopic dermatitis market to reach $16.7b by 2030 across seven major markets
Pharmaceutical firms are urged to capitalise on current trends in AD trials. The atopic dermatitis (AD) market is projected ...
Impacts
9 小时
Eczema on lips can be painful and distressing
Introduction: Eczema, also known as atopic dermatitis, is a common skin condition characterized by dry, itchy skin. While ...
dermatologyadvisor
12 小时
Pediatric Atopic Dermatitis: Dupilumab Normalizes Inflammatory Biomarkers
Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.
The Asian Parent on MSN
6 天
Atopic Dermatitis in Kids: What Every Parent Should Know
Don’t let eczema control your child's life! Discover expert tips on managing atopic dermatitis for a happier, itch-free ...
18 小时
UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late ...
UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced ADESOS Phase 2b results selected as a late-breaking oral ...
Medscape
6 天
FDA Approves Lebrikizumab for Atopic Dermatitis
The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...
verywellhealth
4 天
Is Eczema an Autoimmune Disease or Something Else?
Eczema is a chronic skin condition that shares similarities with autoimmune skin conditions, but it’s not an autoimmune ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈